ALTEPLASE and CHEST PAIN

Overview

CHEST PAIN is the #17 most commonly reported adverse reaction for ALTEPLASE, manufactured by Genentech, Inc.. There are 270 FDA adverse event reports linking ALTEPLASE to CHEST PAIN. This represents approximately 1.2% of all 22,483 adverse event reports for this drug.

Patients taking ALTEPLASE who experience chest pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CHEST PAIN is a less commonly reported adverse event for ALTEPLASE, but still significant enough to appear in the safety profile.

Other Side Effects of ALTEPLASE

In addition to chest pain, the following adverse reactions have been reported for ALTEPLASE:

• NO ADVERSE EVENT — 2,461 reports
• OFF LABEL USE — 1,820 reports
• DEATH — 1,181 reports
• GINGIVAL BLEEDING — 1,017 reports
• CEREBRAL HAEMORRHAGE — 795 reports
• HAEMORRHAGE INTRACRANIAL — 724 reports
• DRUG INEFFECTIVE — 607 reports
• ANGIOEDEMA — 605 reports
• HAEMORRHAGE — 566 reports
• HAEMORRHAGIC TRANSFORMATION STROKE — 423 reports

Other Drugs Associated with CHEST PAIN

The following drugs have also been linked to chest pain in FDA adverse event reports:

Does ALTEPLASE cause CHEST PAIN?

CHEST PAIN has been reported as an adverse event in 270 FDA reports for ALTEPLASE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CHEST PAIN with ALTEPLASE?

CHEST PAIN accounts for approximately 1.2% of all adverse event reports for ALTEPLASE, making it a notable side effect.

What should I do if I experience CHEST PAIN while taking ALTEPLASE?

If you experience chest pain while taking ALTEPLASE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages